@article{d2097bc78a00490abda676f9c8780bb7,
title = "Prediction of outcomes in chronic lymphocytic leukemia patients treated with ibrutinib: Validation of current prognostic models and development of a simplified three-factor model",
author = "Stefano Molica and Diana Giannarelli and Andrea Visentin and Gianluigi Reda and Paolo Sportoletti and Frustaci, \{Anna Maria\} and Annalisa Chiarenza and Stefania Ciolli and Candida Vitale and Luca Laurenti and \{De Paoli\}, Lorenzo and Roberta Murru and Massimo Gentile and Riccardo Moia and Rigolin, \{Gian Matteo\} and Luciano Levato and Annamaria Giordano and \{Del Poeta\}, Giovanni and Caterina Stelitano and Marina Deodato and Claudia Ielo and Alessandro Noto and Valerio Guarente and Marta Coscia and Alessandra Tedeschi and Gianluca Gaidano and Antonio Cuneo and Robin Foa' and Livio Trentin and Mauro, \{Francesca Romana\}",
note = "Funding Information: SM received honoraria from Janssen, Abbvie, and AstraZeneca, advisory board for Janssen, Abbvie, and AstraZeneca. AV received honoraria from Janssen, Abbvie, CSL Behring, Italfarmaco. LT received research funding from Gilead, Roche, Janssen and Takeda, advisory board for Roche, Takeda, Abbvie, AstraZeneca. GMR received research funding from Gilead. FRM advisory board for Janssen, Takeda, and Abbvie. An Cu advisory board and speaker bureau for Roche, Abbvie, Gilead, and Janssen. RF advisory board and speaker bureau for Roche, Abbvie, Celgene, Incyte, Amgen, Janssen, Gilead, and Novartis. LL received honoraria from Abbvie, Janssen, Astra Zeneca, Beigene. ",
year = "2022",
month = may,
doi = "10.1002/ajh.26502",
language = "English",
volume = "97",
pages = "E176--E180",
journal = "American Journal of Hematology",
issn = "0361-8609",
publisher = "John Wiley and Sons Inc.",
number = "5",
}